Xencor reported $44.88M in Trade Debtors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Alnylam Pharmaceuticals ALNY:US USD 184.51M 42.24M
Amgen AMGN:US USD 5.33B 1000K
Arrowhead Research ARWR:US USD 1.41M 1.17M
AstraZeneca AZN:LN USD 10.06B 449M
Biogen BIIB:US USD 1.98B 19.3M
Bristol Myers Squibb BMY:US USD 13.24B 700M
Cytokinetics CYTK:US USD 2.29M 321K
GlaxoSmithKline GSK:LN GBP 8.09B 1.22B
Karyopharm Therapeutics KPTI:US USD 27.45M 3.97M
Macrogenics MGNX:US USD 13.84M 4.55M
Novartis NOVN:VX USD 8.68B 230M
Regeneron Pharmaceuticals REGN:US USD 5.55B 386.9M
Roche Holding ROG:VX 11.08B 48M
Seattle Genetics SGEN:US USD 486.76M 48.71M
Xencor XNCR:US USD 44.88M 9.41M